Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Perrigo Sales Up 39% On Big Brand Equivalents, Firm Expects Big Box Boost

This article was originally published in The Tan Sheet

Executive Summary

Perrigo reached record growth in its latest quarter on the launches of Prilosec OTC and Zyrtec equivalents, and the private-labeler's momentum will likely build further as market conditions ripen for store brand success

You may also be interested in...



Perrigo Bets On Mexican Private Label Growth With Laboratorios Diba Buy

Perrigo is betting the Mexican store-brand market will grow the way private label did in the U.S. 20 years ago, with its $25 million acquisition of Laboratorios Diba

Perrigo Bets On Mexican Private Label Growth With Laboratorios Diba Buy

Perrigo is betting the Mexican store-brand market will grow the way private label did in the U.S. 20 years ago, with its $25 million acquisition of Laboratorios Diba

Perrigo Bets On Mexican Private Label Growth With Laboratorios Diba Buy

Perrigo is betting the Mexican store-brand market will grow the way private label did in the U.S. 20 years ago, with its $25 million acquisition of Laboratorios Diba

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS101646

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel